Literature DB >> 30322808

High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis.

Xinyue Song1, Chaoran Zhao1, Longyang Jiang1, Shu Lin1, Jia Bi1, Qian Wei1, Lifeng Yu1, Lin Zhao2, Minjie Wei3.   

Abstract

BACKGROUND: Pituitary homeobox 1 (PITX1) is a member of the PITX gene family which is vital to proper development of early embryo. However, the relationship of PITX1 expression and overall survival (OS) in non-small cell lung cancer (NSCLC) is not clear.
METHODS: In our study, bioinformatic analysis was performed using UCSC Xena Browser. We used data based on the Cancer Genome Atlas-lung cancer (TCGA-LUNG). Kaplan Meier curves of overall survival were used to investigate the association between PITX1 gene expression and OS in NSCLC patients by the UCSC Xena browser.
RESULTS: Compared with normal lung tissue, PITX gene family was upregulated in NSCLC. Furthermore, higher PITX1 expression was significantly associated with worse OSin 2 yrs., 5 yrs. and 10 yrs. OS (p =  0.004754, 0.01469, 0.02935 respectively) in lung adenocarcinoma (LUAD) patients, but not in lung squamous cell carcinoma (LUSC) patients. PITX1 expression increased in male patients, advanced TNM stage, advanced T stage and advanced regional lymph node status of LUAD patients. PITX1 expressed lowest in bronchioid subtype, meanwhile PITX1 expression was highest in squamoid and magnoid subtype. The high DNA methylation of PITX1 indicated the poor OS in LUAD patients. GSEA revealed that inflammatory response, TNFα signaling via NFκB, TGFβ signaling, IL6 JAK STAT3 signaling and interferon Gamma response were significantly enriched in high PITX1 expression.
CONCLUSION: These findings suggested that PITX1 might serve as a potential biomarker for early detection and prognosis prediction of LUAD patients.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  DNA methylation; Lung adenocarcinoma; Overall survival; PITX1

Mesh:

Substances:

Year:  2018        PMID: 30322808     DOI: 10.1016/j.prp.2018.09.025

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

1.  DNA Methylation-Mediated Low Expression of CFTR Stimulates the Progression of Lung Adenocarcinoma.

Authors:  Yue Wang; Lu Tang; Liangliang Yang; Peiyun Lv; Shixiong Mai; Li Xu; Zhenxing Wang
Journal:  Biochem Genet       Date:  2021-09-08       Impact factor: 1.890

Review 2.  DNA methylation in pulmonary fibrosis and lung cancer.

Authors:  Juan Duan; Baiyun Zhong; Zhihua Fan; Hao Zhang; Mengmeng Xu; Xiangyu Zhang; Yan Y Sanders
Journal:  Expert Rev Respir Med       Date:  2022-06-08       Impact factor: 4.300

3.  Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.

Authors:  Alice Bradfield; Lucy Button; Josephine Drury; Daniel C Green; Christopher J Hill; Dharani K Hapangama
Journal:  Methods Protoc       Date:  2020-09-03

4.  ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.

Authors:  Ze Yu; Weifan Cao; Yuan Ren; Qijia Zhang; Jia Liu
Journal:  Clin Transl Med       Date:  2020-04-07

5.  The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma.

Authors:  Chunyi Zhang; Xing Chen; Yefeng Chen; Miaoying Cao; Jixian Tang; Bo Zhong; Meng He
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

6.  ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.

Authors:  Xiang Cao; Xin-Ming Chen; Wei-Zhang Xiao; Ben Li; Bo Zhang; Qiong Wu; Qun Xue
Journal:  Int J Mol Med       Date:  2020-12-15       Impact factor: 4.101

7.  The expression patterns and prognostic significance of pleckstrin homology-like domain family A (PHLDA) in lung cancer and malignant mesothelioma.

Authors:  Camila M Baldavira; Juliana Machado-Rugolo; Tabatha G Prieto; Daniel R Bastos; Marcelo Balancin; Alexandre M Ab'Saber; Lygia B Yaegashi; Paola C Souza; Cecilia Farhat; Teresa Y Takagaki; Maria Ap Nagai; Vera L Capelozzi
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

8.  Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.

Authors:  Yinglang Zhang; Zhe Zhang; Wei Zhang; Hailong Hu; Guochang Bao
Journal:  Dis Markers       Date:  2021-11-23       Impact factor: 3.434

9.  PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power.

Authors:  Alexandra M Poos; Cornelia Schroeder; Neeraja Jaishankar; Daniela Röll; Marcus Oswald; Jan Meiners; Delia M Braun; Caroline Knotz; Lukas Frank; Manuel Gunkel; Roman Spilger; Thomas Wollmann; Adam Polonski; Georgia Makrypidi-Fraune; Christoph Fraune; Markus Graefen; Inn Chung; Alexander Stenzel; Holger Erfle; Karl Rohr; Aria Baniahmad; Guido Sauter; Karsten Rippe; Ronald Simon; Rainer Koenig
Journal:  Cancers (Basel)       Date:  2022-03-01       Impact factor: 6.639

10.  A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.

Authors:  Xuelong Wang; Bin Zhou; Yuxin Xia; Jianxin Zuo; Yanchao Liu; Xin Bi; Xiong Luo; Chengwei Zhang
Journal:  BMC Cancer       Date:  2021-07-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.